INDIANAPOLIS, IN and SEVILLE, SPAIN -- (MARKET WIRE) -- October 04, 2006 -- neoCodex, SL a pioneer of whole genome discovery, today introduced Hypothesis-Free Clinical Cloning (HFCC), a breakthrough technology for conducting whole genome association studies (WGAS). HFCC is an analysis engine that enables researchers to rapidly analyze millions of SNPs from many individuals to identify specific points of variation in human DNA that underlie particular diseases or determine effects of medicines. HFCC represents the only whole genome analysis tool that systematically generates quality genetic leads from the whole genome analysis itself to remove the burden of scientific guesswork and pathway analysis to produce valid genomic targets.
